Results 111 to 120 of about 2,355 (177)

Upadacitinib and its role in the treatment of vitiligo: A new possible therapeutic perspective

JAAD Case Reports
Jorge Magdaleno-Tapial, PhD, Pablo Hernández-Bel, PhD, Altea Esteve-Martínez, PhD, Rodrigo Peñuelas-Leal, MD, Carolina Labrandero-Hoyos, MD, José Luis Sánchez-Carazo, PhD, Amparo Pérez-Ferriols, PhD   +6 more
doaj   +1 more source

Microneedling for Cutaneous Manifestations of Autoimmune Disease: A Scoping Review. [PDF]

Cureus
Juriga J, Rankin EK, Rodriguez M, Atiquzzaman NT, Morello A, Pedreira C, McKinley MT, Krulikowski K, Ilyas D, Prado Escobar D, Tehrani L, Williams S, Jacobs RJ.   +12 more
europepmc   +1 more source

A Scoping Review of Pathogenesis, Current Treatments, and Novel Approaches for Vitiligo. [PDF]

J Cosmet Dermatol
Sallehuddin N, Fadilah NIM, Fauzi MB, Maarof M.   +3 more
europepmc   +1 more source

Vitiligo: Ruxolitinib and Other Oral Treatment Options Beyond Ruxolitinib. [PDF]

Skin Res Technol
Ghani H, Tan IJ, Ghofrani S, Tchack M, Rao B.   +4 more
europepmc   +1 more source

Immunological aspects of halo nevus (Sutton's Nevus). [PDF]

Front Immunol
Hlača N, Vičić M, Prpić-Massari L.
europepmc   +1 more source

Comparative Study on the Therapeutic Efficacy of Topical Bimatoprost (0.03%) Ophthalmic Solution and Tacrolimus (0.1%) Ointment in Stable Vitiligo. [PDF]

Dermatol Pract Concept
Kalawat R, Saxena K, Jamil RA, Rizvi DA, Ketki, Bansal B, Singh A.   +6 more
europepmc   +1 more source

A 5-week low-dose prednisolone regimen for progressive vitiligo: efficacy and safety in a single-center cohort study. [PDF]

Ann Med
Qian YT, Liu JW, Ma DL.
europepmc   +1 more source

JAK Inhibitors in Down Syndrome: Alopecia Areata Resolution and Vitiligo Improvement with Baricitinib. [PDF]

Acta Derm Venereol
Li Pomi F, Vaccaro M, Vitale M, Alaimo R, Borgia F.   +4 more
europepmc   +1 more source